Lipocalin 2 Participates in the Epidermal Differentiation and Inflammatory Processes of Psoriasis
Kaixuan Ren,Yumin Xia
DOI: https://doi.org/10.2147/JIR.S358492
IF: 4.5
2022-04-01
Journal of Inflammation Research
Abstract:Kaixuan Ren, Yumin Xia Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, People's Republic of China Correspondence: Yumin Xia, Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an, 710004, People's Republic of China, Tel/Fax +86-29-87679969, Email As a multifunctional cytokine, lipocalin 2 is weakly expressed in skin and serum under normal conditions. However, it is over-expressed by neutrophils and keratinocytes in the skin lesions and sera in several skin diseases. Recent studies demonstrated that lipocalin 2 participates in the pathogenesis of psoriasis by exerting versatile effects on skin resident cells and infiltrating immune cells. Lipocalin 2 inhibits the synthesis of keratin, involucrin, and loricrin in keratinocytes, leading to epidermal parakeratosis via the Tcf7l1-lipocalin 2 signaling axis. It also recruits inflammatory cells such as T cells and neutrophils into skin lesions via the IL-23/IL17, p38-MAPK, and ERK-1/2 signaling pathways. Additionally, lipocalin 2 and other cytokines such as IL-17 have the synergetic effects on skin cells. The neutralization of lipocalin 2 or relevant cytokines can alleviate psoriasis, verifying that lipocalin 2 is an effective interfering target for psoriasis. In this review, we summarize the roles of lipocalin 2 in the processes of psoriatic inflammation and the promising therapeutic strategies based on lipocalin 2-related molecules. Keywords: lipocalin 2, psoriasis, keratinocyte, inflammation, differentiation Psoriasis is a common, chronic, immune-mediated dermatosis affected by genetic and environmental factors that can be triggered by injuries, infections, or mechanical stimulation. 1 The fundamental mechanism of psoriasis consists of three main aspects: immune and inflammatory cell infiltration, vascular proliferation and skin hyperplasia, 2 and abnormal differentiation of keratinocytes. 3,4 In terms of immune mediation, activated CD4+, CD8+ T lymphocytes, CD3 T cells, macrophages, mast cells, 5 keratinocytes, dendritic cells, and neutrophils lead to innate and adaptive immune responses by the release of cytokines and enzymes in psoriasis. 6–8 During the inflammation process, interleukin (IL)-23 and IL-12, secreted by dendritic cells, activate Th1 and Th17 cells to produce cytokines such as IL-17, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α. This leads to macrophage migration, keratinocyte proliferation, 9 and neovascularization, subsequently resulting in the appearance of psoriatic scaly plaques. Lipocalin 2 is a 25-kDa glycoprotein coded in a gene located at chromosome 9q34.11, and it is composed of an N-linked low-molecular weight polysaccharide and a protein backbone. With this kind of structure, lipocalin 2 can bind with three receptors including megalin, 10 24p3R, and melanocortin-4. It possesses a lipophilic barrel-shaped tertiary structure and binds with matrix metalloproteinase (MMP)-9 in neutrophils for the inhibition of proteolysis of MMP-9. 11,12 In addition to secretion by granulocytes, lipocalin 2 is mainly secreted by a variety of cells, including keratinocytes, 13 adipocytes, 14 CD4+ T cells, 15 macrophages, 16 and dendritic cells. 17 It is also produced in different tissues such as the liver, lungs, and kidneys. 18 Lipocalin 2 is widely expressed, although it was initially considered as an antimicrobial peptide that was increased in the plasma and tissues of patients with infectious diseases. In recent years, studies have shown that lipocalin 2 levels are also elevated in several inflammatory skin diseases such as psoriasis, 19,20 eczema, and skin wounds, 21 and its overexpression has even been detected in neoplasms for its potential role in cell proliferation in diseases such as keratoacanthoma and squamous cell carcinoma. 22,23 Thus, lipocalin 2 functions in a versatile manner in antibiosis, inflammation, and cell differentiation or dysfunction. Several studies have shown that lipocalin 2 levels are elevated in the skin lesions and serum of patients with psoriasis, and lipocalin 2 has been proved to be effective in regulating inflammation and cell proliferation in psoriasis. 24 There has been a large number of articles highlighting lipocalin 2ʹs versatile functions, such as being an indicator for predicting the prognosis and mortality of neoplasms and psoriasis. However, there are few convincing pieces of evidence that highlight the diagnostic and treatment value of lipocalin 2. The relationship between lipocalin 2 and the onset or development of psoriasis remains unclear and should be elucidated. Here, we review the current findings reg -Abstract Truncated-
immunology